Singapore, Nov. 11 -- Certara, a global leader in biosimulation, recently announced the opening of a new office in Shanghai's Pudong District, China's epicentre for biopharmaceutical research and development (R&D). The office will allow Certara to strengthen its collaboration with customers in the rapidly growing Chinese biopharmaceutical industry. The company is recruiting an outstanding China-based team for business development and biopharmaceutical R&D services.

"We recognise the tremendous growth of China's biopharmaceutical industry and are thrilled to have a direct presence in China so that we can fully support our rapidly growing Chinese customer base," said William F Feehery, CEO, Certara. "Certara's extensive experience in biosi...